Physician profile
Jonathan Young
NPI 1720492820
$1,439.46
in general payments reported to CMS, 2019-2025
8 companies · $614 in 2025
The $614 reported for 2025 was more than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $22.13 · 2023: $376 · 2024: $427 · 2025: $614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,378 · Honoraria: $38.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,378.47 |
| Honoraria | $38.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $395.59 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Alcon Vision LLC | $385.92 | 2023-2025 | Wavelight Refractive Suite, Clareon, Hydrus Microstent |
| Abbvie INC. | $351.56 | 2023-2025 | Xen Glaucoma Treatment System, Durysta |
| Glaukos Corporation | $196.75 | 2024-2025 | Radius, Idose, Kxl System (Not Refurbished) |
| Bausch & Lomb Americas INC. | $37.13 | 2024-2025 | Envista Mx60 Iol, Scoutpro Osmolarity System |
| Sun Pharmaceutical Industries INC. | $29.43 | 2023-2024 | Cequa |
| Heidelberg Engineering, INC. | $22.13 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $20.95 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.